Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Vicarious Surgical Inc (NYSE: RBOT) closed the day trading at $1.96 down -2.00% from the previous closing price of $2.0. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 52966.0 shares were traded. RBOT stock price reached its highest trading level at $2.06 during the session, while it also had its lowest trading level at $1.96.
Ratios:
For a better understanding of RBOT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.75 and its Current Ratio is at 4.75. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In the most recent recommendation for the company, Piper Sandler on March 04, 2022, Downgraded its rating to Neutral and sets its target price to $7 from $16 previously.
On January 07, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $16.
On December 07, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $15.Cowen initiated its Outperform rating on December 07, 2021, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 03 ’25 when Sachs Adam David sold 463 shares for $2.95 per share. The transaction valued at 1,367 led to the insider holds 47,885 shares of the business.
Khalifa Sammy sold 239 shares of RBOT for $710 on Dec 03 ’25. The Chief Technology Officer now owns 33,623 shares after completing the transaction at $2.97 per share. On Dec 03 ’25, another insider, Adam Sachs, who serves as the Officer of the company, bought 463 shares for $2.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RBOT now has a Market Capitalization of 13949793 and an Enterprise Value of 12306595.
Stock Price History:
The Beta on a monthly basis for RBOT is 1.52, which has changed by -0.8353909 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, RBOT has reached a high of $18.97, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is -48.27%, while the 200-Day Moving Average is calculated to be -69.90%.
Shares Statistics:
Over the past 3-months, RBOT traded about 119.87K shares per day on average, while over the past 10 days, RBOT traded about 104980 shares per day. A total of 5.31M shares are outstanding, with a floating share count of 3.95M. Insiders hold about 44.72% of the company’s shares, while institutions hold 9.20% stake in the company. Shares short for RBOT as of 1764288000 were 151012 with a Short Ratio of 1.73, compared to 1761868800 on 182741. Therefore, it implies a Short% of Shares Outstanding of 151012 and a Short% of Float of 3.61.
Earnings Estimates
. The current assessment of Vicarious Surgical Inc (RBOT) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$1.2, with high estimates of -$1.2 and low estimates of -$1.2.
Analysts are recommending an EPS of between -$8.09 and -$8.09 for the fiscal current year, implying an average EPS of -$8.09. EPS for the following year is -$4.07, with 1.0 analysts recommending between -$4.07 and -$4.07.
